BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16446544)

  • 1. Levalbuterol inhibits human airway smooth muscle cell proliferation: therapeutic implications in the management of asthma.
    Ibe BO; Portugal AM; Raj JU
    Int Arch Allergy Immunol; 2006; 139(3):225-36. PubMed ID: 16446544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms by which S-albuterol induces human bronchial smooth muscle cell proliferation.
    Ibe BO; Abdallah MF; Raj JU
    Int Arch Allergy Immunol; 2008; 146(4):321-33. PubMed ID: 18362475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albuterol isomers modulate platelet-activating factor synthesis and receptor signaling in human bronchial smooth muscle cells.
    Bae R; Arteaga A; Raj JU; Ibe BO
    Int Arch Allergy Immunol; 2012; 158(1):18-26. PubMed ID: 22212397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The asthma-like pharmacology and toxicology of (S)-isomers of beta agonists.
    Handley D
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S69-76. PubMed ID: 10452791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic inhibition by beta(2)-agonists and corticosteroids on tumor necrosis factor-alpha-induced interleukin-8 release from cultured human airway smooth-muscle cells.
    Pang L; Knox AJ
    Am J Respir Cell Mol Biol; 2000 Jul; 23(1):79-85. PubMed ID: 10873156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levalbuterol: pharmacologic properties and use in the treatment of pediatric and adult asthma.
    Berger WE
    Ann Allergy Asthma Immunol; 2003 Jun; 90(6):583-91; quiz 591-2, 659. PubMed ID: 12839314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human airway smooth muscle cell proliferation by beta 2-adrenergic receptors and cAMP is PKA independent: evidence for EPAC involvement.
    Kassel KM; Wyatt TA; Panettieri RA; Toews ML
    Am J Physiol Lung Cell Mol Physiol; 2008 Jan; 294(1):L131-8. PubMed ID: 17993585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of TNF-alpha-induced eotaxin release from cultured human airway smooth muscle cells by beta2-agonists and corticosteroids.
    Pang L; Knox AJ
    FASEB J; 2001 Jan; 15(1):261-269. PubMed ID: 11149914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of GM-CSF release by enantiomers of beta-agonists in human airway smooth muscle.
    Ameredes BT; Calhoun WJ
    J Allergy Clin Immunol; 2005 Jul; 116(1):65-72. PubMed ID: 15990776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salbutamol inhibits the proliferation of human airway smooth muscle cells grown in culture: relationship to elevated cAMP levels.
    Tomlinson PR; Wilson JW; Stewart AG
    Biochem Pharmacol; 1995 Jun; 49(12):1809-19. PubMed ID: 7598743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-mitogenic effects of β-agonists and PGE2 on airway smooth muscle are PKA dependent.
    Yan H; Deshpande DA; Misior AM; Miles MC; Saxena H; Riemer EC; Pascual RM; Panettieri RA; Penn RB
    FASEB J; 2011 Jan; 25(1):389-97. PubMed ID: 20805374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta 2-adrenoceptor agonist-mediated inhibition of human airway smooth muscle cell proliferation: importance of the duration of beta 2-adrenoceptor stimulation.
    Stewart AG; Tomlinson PR; Wilson JW
    Br J Pharmacol; 1997 Jun; 121(3):361-8. PubMed ID: 9179374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (S)-Albuterol activates pro-constrictory and pro-inflammatory pathways in human bronchial smooth muscle cells.
    Agrawal DK; Ariyarathna K; Kelbe PW
    J Allergy Clin Immunol; 2004 Mar; 113(3):503-10. PubMed ID: 15007354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with levalbuterol.
    Nelson HS
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S77-84. PubMed ID: 10452792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-isomer levalbuterol: a review of the acute data.
    Nowak R
    Curr Allergy Asthma Rep; 2003 Mar; 3(2):172-8. PubMed ID: 12562558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levalbuterol in the treatment of patients with asthma and chronic obstructive lung disease.
    Dalonzo GE
    J Am Osteopath Assoc; 2004 Jul; 104(7):288-93. PubMed ID: 15293593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting properties of albuterol stereoisomers.
    Page CP; Morley J
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S31-41. PubMed ID: 10452786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta2-adrenergic receptor agonists and cAMP arrest human cultured airway smooth muscle cells in the G(1) phase of the cell cycle: role of proteasome degradation of cyclin D1.
    Stewart AG; Harris T; Fernandes DJ; Schachte LC; Koutsoubos V; Guida E; Ravenhall CE; Vadiveloo P; Wilson JW
    Mol Pharmacol; 1999 Nov; 56(5):1079-86. PubMed ID: 10531416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma.
    Nelson HS; Bensch G; Pleskow WW; DiSantostefano R; DeGraw S; Reasner DS; Rollins TE; Rubin PD
    J Allergy Clin Immunol; 1998 Dec; 102(6 Pt 1):943-52. PubMed ID: 9847435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide-dependent beta2-adrenergic dilatation of rat aorta is mediated through activation of both protein kinase A and Akt.
    Ferro A; Coash M; Yamamoto T; Rob J; Ji Y; Queen L
    Br J Pharmacol; 2004 Oct; 143(3):397-403. PubMed ID: 15351777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.